Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Tome creates decreases

.After raising $213 million in 2023-- among the year's largest exclusive biotech rounds-- Tome Biosc...

BioMarin constructs director group with biotech vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Biopharma Q2 VC reached highest level considering that '22, while M&ampA slowed

.Venture capital backing into biopharma cheered $9.2 billion throughout 215 deals in the second four...

Bicara, Zenas look for IPOs to drive late-phase properties towards market

.Bicara Therapeutics and also Zenas Biopharma have actually provided new inspiration to the IPO mark...

Genentech to finalize cancer immunology study division

.Genentech will definitely shut its own cancer immunology study department, as well as unit mind and...

Kezar goes down strong cyst but to verify its own worth in period 1 test

.Kezar Life Sciences is losing its own dim period 1 strong tumor medication as the biotech goes all-...

Acelyrin drops izokibep, dismisses 3rd of personnel

.Regardless of izokibep maintaining its own newfound winning touch in the medical clinic, Acelyrin i...

Rivus' period 2 obesity-related cardiac arrest trial strikes endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid stops preclinical work, IV program after soticlestat neglect

.Ovid Rehab actually revealed last month that it was trimming back its headcount as the provider bro...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston Seaport

.Eli Lilly has opened a $700 million R&ampD center in the Boston ma Port, improving its own RNA and ...